Abstract
Background
Treatment of locally recurrent gastric neoplasms after endoscopic resection remains challenging. We investigated the efficacy and safety of treatment options for recurrent gastric neoplasms localized to the scar of previous endoscopic submucosal dissection (ESD).
Methods
The clinicopathological characteristics and treatment outcomes of patients who underwent endoscopic treatment or surgery for recurrent gastric neoplasms between June 2010 and May 2017 were retrospectively reviewed.
Results
Of the 92 patients included, 74 underwent endoscopic treatment (51 redo ESD, 23 argon plasma coagulation [APC] ablation) and 18 underwent surgery. The redo ESD procedure time was significantly longer than that of the primary ESD (31.0 versus 22.0 min, p = 0.018). Overall, adverse events occurred in 11 patients (12.0%), with the incidence being significantly higher in the surgery group (27.8% versus 8.1% in the endoscopic treatment group, p = 0.036). Local recurrence-free survival rates were 81.1% for the endoscopic treatment group (86.3% and 69.6% for redo ESD and APC groups, respectively) and 100% for the surgery group (log rank p = 0.033). Logistic regression analysis showed that tumor size > 12.5 mm (odds ratio [OR] 5.14, 95% confidence interval [CI] 1.25–26.9, p = 0.032) and tumors located in the upper two-thirds of the stomach (OR 4.43, 95% CI 1.27–16.8, p = 0.023) were associated with non-curative resection after redo ESD.
Conclusions
Endoscopic treatment could be an effective and safe alternative to surgery for selected patients with gastric neoplasms recurring at the scar of previous ESD. Especially, patients having small lesions located in the distal part of the stomach could be a good candidate for redo ESD.
Similar content being viewed by others
References
Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. Journal of Gastroenterology 2006;41:929–942.
Chiu PWY, Teoh AYB, To KF, Wong SKH, Liu SYW, Lam CCH, Yung MY, Chan FKL, Lau JYW, Ng EKW. Endoscopic submucosal dissection (ESD) compared with gastrectomy for treatment of early gastric neoplasia: a retrospective cohort study. Surgical Endoscopy 2012;26:3584–3591.
Park CH, Lee H, Kim DW, Chung H, Park JC, Shin SK, Hyung WJ, Lee SK, Lee YC, Noh SH. Clinical safety of endoscopic submucosal dissection compared with surgery in elderly patients with early gastric cancer: a propensity-matched analysis. Gastrointestinal Endoscopy 2014;80:599–609.
Degiuli M, Sasako M, Ponti A, Vendrame A, Tomatis M, Mazza C, Borasi A, Capussotti L, Fronda G, Morino M, Italian Gastric Cancer Study Group. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014;101:23–31.
Svedlund J, Sullivan M, Liedman B, Lundell L. Long term consequences of gastrectomy for patients’ quality of life: the impact of reconstructive techniques. The American Journal of Gastroenterology 1999;94:438–445.
Lee SS, Chung HY, Kwon OK, Yu W. Long-term Quality of Life After Distal Subtotal and Total Gastrectomy: Symptom- and Behavior-oriented Consequences. Annals of Surgery 2016;263:738–744.
Jung SJ, Cho S-J, Choi IJ, Kook M-C, Kim CG, Lee JY, Park SR, Lee JH, Ryu KW, Kim Y-W. Argon plasma coagulation is safe and effective for treating smaller gastric lesions with low-grade dysplasia: a comparison with endoscopic submucosal dissection. Surgical Endoscopy 2013;27:1211–1218.
Hirasawa K, Kokawa A, Oka H, Yahara S, Sasaki T, Nozawa A, Tanaka K. Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointestinal Endoscopy;72:960–966.
Lim C-H, Park JM, Park C-H, Cho YK, Lee IS, Kim SW, Choi M-G, Chung I-S. Endoscopic Submucosal Dissection of Gastric Neoplasia Involving the Pyloric Channel by Retroflexion in the Duodenum. Digestive Diseases and Sciences 2012;57:148–154.
Yokoi C, Gotoda T, Hamanaka H, Oda I. Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection. Gastrointestinal Endoscopy 2006;64:212–218.
Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kanao H, Kawamura T, Yoshida S, Yoshihara M, Chayama K. Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection. Endoscopy 2006;38:996–1000.
Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1–19.
Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101–112.
Dindo D, Demartines N, Clavien P-A. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Annals of Surgery 2004;240:205–213.
Huscher CGS, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C. Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric Cancer: Five-Year Results of a Randomized Prospective Trial. Annals of Surgery 2005;241:232–237.
Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N, the Japanese Laparoscopic Surgery Study G. A Multicenter Study on Oncologic Outcome of Laparoscopic Gastrectomy for Early Cancer in Japan. Annals of Surgery 2007;245:68–72.
Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer 2007;10:1–11.
Higashimaya M, Oka S, Tanaka S, Numata N, Sanomura Y, Yoshida S, Arihiro K, Chayama K. Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection. Gastrointestinal Endoscopy 2013;77:298–302.
Kitamura T, Tanabe S, Koizumi W, Mitomi H, Saigenji K. Argon plasma coagulation for early gastric cancer: technique and outcome. Gastrointestinal Endoscopy 2006;63:48–54.
Tomita T, Arai E, Kohno T, Kondo T, Kim Y, Oshima T, Hori K, Watari J, Matsumoto T, Miwa H. Outcomes of Treatment of Argon Plasma Coagulation Therapy in Elderly or High-risk Patients With Early Gastric Cancer: A Comparison of Outcomes Among Experienced and Nonexperienced Endoscopists. Journal of Clinical Gastroenterology 2011;45:e54-e59.
Gong EJ, Ahn JY, Jung HY, Park YS, Na HK, Jung KW, Kim DH, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH. Effects of argon plasma coagulation on human stomach tissue: An ex vivo study. Journal of Gastroenterology and Hepatology 2017;32:1040–1045.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the institutional review board of the Asan Medical Center (registration number 2017-0641).
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Supplementary Figure 1
Receiver operator characteristics curve for non-curative resection after redo endoscopic submucosal dissection according to the size of the tumor. (PNG 66 kb)
Supplementary Table 1
(DOCX 16 kb)
Rights and permissions
About this article
Cite this article
Choi, Y.K., Kim, D.H., Gong, E.J. et al. Comparison Between Redo Endoscopic Treatment and Surgery in Patients with Locally Recurrent Gastric Neoplasms. J Gastrointest Surg 24, 1489–1498 (2020). https://doi.org/10.1007/s11605-019-04303-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-019-04303-z